Bnt326

2 trials 2 recruiting

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

2 Recruiting

0 Completed trials

1 Sponsors

5 Countries

Phase I/II

Phase I/II: 2

Indications tested

Squamous cell carcinoma of lung 1 HER2 mutant non-small cell lung cancer 1 Non-small cell lung cancer stage III 1 Non-small cell lung cancer stage IV 1 Non-small cell lung cancer recurrent 1 Non-small cell lung cancer metastatic 1 Non-small cell lung cancer stage IIIB 1 Non-small cell lung cancer 1 Non-small cell lung cancer stage IIIA 1

Sponsors using this IMP

All trials

2 total

A clinical trial to test if an investigational combination therapy with BNT326 and BNT327 is safe and potentially beneficial for people with… Recruiting

2024-519344-32-00 Phase I/II 4 countries BioNTech SE
A clinical study to test if an investigational treatment called BNT326 is safe and potentially beneficial when used alone or in combination … Recruiting

2024-517261-16-00 Phase I/II 4 countries BioNTech SE

Showing 1–2 of 2 trials

← All drugs A–Z